Rhinomed Ltd
ASX:RNO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Rhinomed Ltd
Revenue
Rhinomed Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Rhinomed Ltd
ASX:RNO
|
Revenue
AU$7.5m
|
CAGR 3-Years
28%
|
CAGR 5-Years
28%
|
CAGR 10-Years
94%
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Revenue
AU$1.1m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Revenue
AU$413m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Revenue
AU$76.8m
|
CAGR 3-Years
69%
|
CAGR 5-Years
145%
|
CAGR 10-Years
44%
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Revenue
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vita Life Sciences Ltd
ASX:VLS
|
Revenue
AU$93.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
15%
|
CAGR 10-Years
9%
|
|
Rhinomed Ltd
Glance View
Rhinomed Ltd. is medical technology company, which engages in the identification, acquisition, and commercialization of stage therapeutic delivery technologies. The company is headquartered in Richmond, Victoria. The company went IPO on 2007-09-21. The Company’s products include Mute, Turbine, Pronto Sleep, and Pronto Clear. The Mute is a nasal technology that is designed to allow the user to manage the sleep by breathing more and snoring less. The Turbine is a nasal dilator designed to assist the user to breathe during aerobic exercise. Pronto Sleep, which combines the benefits of a nasal dilator, to open the nose and improve airflow, with the soothing vapors of four pure essential oils. Pronto Clear, which combines the benefits of a nasal dilator, to open the nose and improve airflow, with the ability to deliver the vapors of six pure essential oils traditionally known to clear a stuffy nose naturally. Its products, including Turbine and Mute, are sold online and through pharmacies, sleep clinics, and sports stores.
See Also
What is Rhinomed Ltd's Revenue?
Revenue
7.5m
AUD
Based on the financial report for Jun 30, 2023, Rhinomed Ltd's Revenue amounts to 7.5m AUD.
What is Rhinomed Ltd's Revenue growth rate?
Revenue CAGR 10Y
94%
Over the last year, the Revenue growth was -18%. The average annual Revenue growth rates for Rhinomed Ltd have been 28% over the past three years , 28% over the past five years , and 94% over the past ten years .
